The Lasker-Koshland Special Achievement Award in Medical Science aims to recognize ''research accomplishments and scientific statesmanship that engender the deepest feelings of awe and respect.'' This is indeed a high bar for any scientist, yet it's such an apt description of Joan Steitz. What is truly remarkable about Joan's RNA research is that discovery has followed discovery for more than 40 years, and her papers and oral presentations are so clear and exciting that her work has had enormous impact on several fields. At the same time, she is an exemplary international leader and statesman for science.
Fixated on RNA-RNA Pairing Joan's scientific career is built on her selfdescribed ''monolithic fixation on RNA-RNA base-pairing'' (Steitz, 2015) . If you're going to be an RNA scientist, that's a pretty good fixation to have. After all, DNA's base-pairing potential is mostly self-satisfied in the double helix. RNA, on the other hand, is a single-stranded nucleic acid, and its intramolecular structure usually leaves some sequences open and available for intermolecular pairing. Complementary base-pairing then makes it easy for RNA to rapidly evolve solutions to molecular recognition problems.
Yet, when Joan began her independent career at Yale University in 1970, the only known example of such RNA-RNA pairing was the mRNA codon-tRNA anticodon interaction. That would soon change. As a postdoc, Joan had isolated and sequenced the first translation initiator regions from the phage R17 mRNA, but no simple sequence motif had appeared. Lynn Dalgarno from the Australian National University in Canberra contacted Joan; he and his student John Shine had sequenced the 3 0 end of 16S rRNA and found complementarity to the few ribosome binding sites of E. coli phage mRNAs then known. Joan leapt to the challenge of testing whether the proposed interaction really occurred. By chewing away the non-complexed RNA, Joan was able to isolate and characterize the rRNA-mRNA hybrid complex, providing direct evidence for the ShineDalgarno hypothesis ( Figure 1A ; Steitz and Jakes, 1975) . This was only the beginning of Joan's contributions to RNA-RNA recognition.
Snurps RNA splicing is a big area of biology, because almost all mammalian genes have their coding sequences interrupted by introns. Thus, mRNA splicing is required for the expression of these genes, and defects in mRNA splicing are a common cause of beta-thalassemia and many other human diseases. Joan's discoveries regarding the mechanism of human pre-mRNA splicing had an unlikely origin in rheumatology. Her student Michael Lerner obtained autoantibodies from Lupus patients and found that some of them reacted with small nuclear ribonucleoprotein particles or snRNPs (pronounced ''snurps''). These autoantibodies provided new tools for understanding snRNP biology. Although the U1 snRNA had been identified in the labs of Harris Busch and Sheldon Penman some years earlier, its function was completely obscure. In her seminal paper, provocatively entitled ''Are snRNPs involved in splicing?'' (Lerner et al., 1980) , Joan and her research group proposed that U1 small nuclear RNA might recognize 5 0 splice sites in premRNA by direct RNA-RNA base-pairing ( Figure 1B ). Fast-forward to the present, and this interaction has now been seen at X-ray crystallographic resolution (Kondo et al., 2015) .
Joan turned much of her lab's effort for the next 30 years toward drilling down into the splicing mechanism. More than once I've observed her engaged in long, detailed discussions with Christine Guthrie and John Abelson, leaders in yeast mRNA splicing, discussing which snRNPs were in the spliceosome at various stages and even what role a particular nucleotide might have in the splicing reaction. It's too bad that these conversations weren't recorded, because they encompassed the essence of good science: passion for the topic, critical evaluation of experimental data, respect for your colleagues' opinions even when you think they're mistaken, and great joy when diverse data come together to shape a unifying model. Now that high-resolution cryo-EM structures of multiple spliceosomal complexes have been solved by the groups of Kiyoshi Nagai, Reinhard Lü hrmann, and Yigong Shi, the astounding accuracy of the models proposed by Joan and her fellow biochemists and geneticists has come to light; see, for example, Hang et al. (2015) .
More Snurps
The concept that small noncoding RNAs mark sites of RNA processing by base-pairing started to expand. Histone pre-mRNAs are not processed by RNA cleavage and polyadenylation, but simply by cleavage. Mowry and Steitz (1987) found that the low-abundance U7 snRNA had a 5 0 end sequence complementary to sequences downstream of the mRNA cleavage site in histone pre-mRNAs, providing a model for cleavage specification ( Figure 1C ). Then there is the alternative or ''minor'' spliceosome, which uses a somewhat different set of snRNPs to splice a rare class of human introns (Hall and Padgett, 1996; Tarn and Steitz, 1996) . Again, it's RNA-RNA base-pairing that recognizes the splice sites and helps form the catalytic center for splicing ( Figure 1D) .
A Rocky Mountain Sojourn
In 1992, Joan and her husband Tom spent a sabbatical year in Boulder with Olke Uhlenbeck and me. This was a productive year for the Steitz's in multiple respects. They wrote their first joint publication, ''A general two-ion mechanism for catalytic RNA,'' which turned out to be prescient with respect to the chemical mechanism of snRNP-catalyzed mRNA splicing (Steitz and Steitz, 1993) . It remains one of the top-cited papers on both of their CV's. Another Steitz-Steitz collaboration, their son Jon, caught fire as a middle-school baseball pitcher that year. He ultimately was drafted by the Milwaukee Brewers. Jon followed the typical major league baseball trajectory: he graduated from Yale with a B.A. in Molecular Biophysics & Biochemistry, then pitched 0 splice-site cleavage (1980), (C) the U7 snRNA-histone pre-mRNA pairing that guides histone pre-mRNA processing (1987), (D) the snRNA-intron and snRNA-snRNA pairings that help specify splicing of the rare class of AT-AC introns (1996) , and (E) the viral EBER2 ncRNA-nascent transcript interaction that recruits the PAX5 transcription factor to the viral terminal repeats (2015) . In all cases, noncoding RNAs are green, mature mRNA sequences (exons) are blue, and sequences removed by RNA processing (including introns) are yellow. Red lines represent intermolecular RNA-RNA base-pairing. Thin arrows in panels B, C, and D represent sites of RNA splicing or cleavage catalyzed by the noncoding RNA.
professionally, then entered and graduated from Yale Law School.
1992 was also the year that Joan, Olke, and I took the legal steps necessary to found the RNA Society, originally as a Colorado non-profit organization. Certainly many other RNA scientists (note especially Tim Nilsen) worked to make it a reality. Our dream was always that young energetic RNA scientists would step forth and forge the Society into a household name for ribo-research internationally. Magically, this is precisely what has happened! The RNA Society is one of Joan's numerous leadership contributions.
Viruses Exploit Base-Pairing to Hijack Host Factors
In recent years, Joan's lab has placed special emphasis on noncoding RNAs produced by viruses to subvert host cell biology. In one recent study, a Herpesvirus saimiri noncoding RNA was found to provide a binding site for a host micro-RNA, miR-27 (Cazalla et al., 2010) . Binding results in degradation of miR-27 with consequent effects on the expression of miR-27 target genes. This was an early example of a ''target-induced microRNA degradation'' function for lncRNAs. A new paradigm was established when Joan's lab reported that an Epstein-Barr virus noncoding RNA attracts the host PAX5 transcription factor by base-pairing (Lee et al., 2015;  Figure 1E ). The common denominator of all these studies is innovation, breaking new ground, and embracing the unexpected.
In a new twist on the base-pairing theme, some viral noncoding RNAs make use of triple helices. A Kaposi's sarcoma-associated herpesvirus nuclear noncoding RNA was found to form a novel triple helical RNA structure with its own poly(A) tail (Mitton-Fry et al., 2010) . The resulting RNA clamp sequesters the poly(A) tail and prevents the initiation of RNA decay. Reasoning that viruses often borrow molecular mechanisms from their hosts, Joan's lab searched for human long-noncoding RNAs that might employ a similar mechanism. They identified 3 0 -terminal triple-helical structures in metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and multiple endocrine neoplasia-b (MENb) lncRNAs (Brown et al., 2012) . In these cases, the stretch of adenine bases that participates in the triple helix is genomically encoded rather than being a post-transcriptional poly(A) tail.
Pioneering the Noncoding RNA Revolution At first glance, Joan's numerous RNA research contributions appear to be spread out over a large number of diverse biological systems. But there's an undeniable theme: it's always a noncoding RNA (green in Figure 1) that's recognizing a messenger RNA or pre-mRNA (blue and orange) and marking it for action. This appreciation for the diverse and critical functions of long noncoding RNAs may seem obvious now (Cech and Steitz, 2014) , but it was the purview of a relatively small cadre of scientists when Joan started her career.
The Next Generation I always judge a scientist not just by their publications and discoveries, but also by the scientists they have mentored. Joan's lab is famous for providing a critical, supportive, and high-octane venue for RNA research. Her passion for RNA has rubbed off on the many successful students and postdoctoral fellows whose careers were launched in Joan's lab. Some former trainees are professors at institutions ranging from M.I.T. and Johns Hopkins to UCLA and UC San Diego, while others have contributed in biotechnology and other scientific careers. Joan's mentorship extends beyond her own trainees, and she has profoundly influenced the career trajectories of young scientists at Yale and at institutions around the world.
Beyond The RNA World Joan's statesmanship is extraordinary. She serves on review panels and advisory committees for universities, research institutes, and funding agencies throughout the world. She worked tirelessly for over a decade to lead the Jane Coffin Childs Fund, which grants postdoctoral fellowships to outstanding young biomedical scientists. She has served on the board or advisory councils for the Rockefeller University, the Sloan Kettering Cancer Center, the Helsinki Institute of Biotechnology, the Rita Allen Foundation, the Salk Institute, M.I.T., the European Molecular Biology Organization, and many others.
Joan is asked to serve on these committees because she is a great scientist whose wise counsel and broad expertise are invaluable. In addition, the respect she engenders has given her an opportunity to speak out for fair treatment of woman scientists, and she has not shirked. She is an outspoken advocate for equal recognition and equal pay (Zernike, 2001 ). Her scientific leadership is broadly acknowledged and has led to her receiving 18 honorary Doctor of Science degrees from institutions spanning the globe from Buenos Aires to Oxford to many U.S. colleges and universities.
Thus, Joan Steitz is a very special scientist with truly exceptional research achievements. Through the example she has set and the leadership she provides, she has served as an ambassador for what is the best in science throughout the world. It's so very appropriate for the Lasker to award her this special recognition.
